Latest news with #insiderTrading
Yahoo
6 hours ago
- Business
- Yahoo
Insiders At Elevance Health Sold US$6.9m In Stock, Alluding To Potential Weakness
Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag. While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Over the last year, we can see that the biggest insider sale was by the Executive VP & President of Commercial Health Benefits, Charles Kendrick, for US$3.2m worth of shares, at about US$432 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (US$384). So it may not tell us anything about how insiders feel about the current share price. In the last year Elevance Health insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Elevance Health If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations. The last quarter saw substantial insider selling of Elevance Health shares. Specifically, insiders ditched US$3.5m worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap. Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own 0.1% of the company, currently worth about US$101m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders. Insiders haven't bought Elevance Health stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. It is good to see high insider ownership, but the insider selling leaves us cautious. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Elevance Health. You'd be interested to know, that we found 1 warning sign for Elevance Health and we suggest you have a look. But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Globe and Mail
a day ago
- Business
- Globe and Mail
Off-market insider buying at Matador Technologies (MATA)
Donato Sferra, a Director and 10% Holder, acquired 100,000 Common Shares on a direct ownership basis at a price of $0.550 through a prospectus or prospectus exempt offering on May 26th, 2025. The insider also acquired 100,000 Common Shares on a control or direction basis for registered holder Margarita Sferra at a price of $0.550 through a prospectus or prospectus exempt offering on May 26th, 2025. This represents a $110,000 investment into the company's shares and an account share holdings change of greater than 100%. Let the insiders guide you to opportunity at
Bloomberg
3 days ago
- Business
- Bloomberg
Indian Stocks to Catch up With Asian Peers in Second Half of 2025
Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at: Good morning, this is Alex Gabriel Simon, an equities reporter in Mumbai. Nifty futures point to a positive opening, following Asian markets higher as a favorable ruling from the US trade court that deemed President Donald Trump's global tariffs illegal lifted investor sentiment. Traders' focus will be on IndusInd Bank following the ban on its former CEO for insider trading and Bajaj Auto's earnings.
CTV News
3 days ago
- Business
- CTV News
Ethics complaint lodged against Manitoba politician over stock sold in wake of CTV article
An ethics complaint has been made against Mike Moroz, Minister of Innovation and New Technology, regarding Telus shares he sold earlier this month. Moroz said that the accusations are baseless. (Glenn Pismenny/CTV News Winnipeg) An ethics complaint has been made against Mike Moroz, Minister of Innovation and New Technology, related to stock he sold in the wake of a CTV News report about a man who died during a Telus outage. Konrad Narth, MLA for La Vérendrye, alleged on Tuesday that Moroz used 'insider information available to him as a minister of the crown to sell personal shares in a corporation before a report that reflects negatively on that corporation was made public.' From March 22 to 24, a Telus outage prevented calls to 911 from going through. On March 23, Dean Switzer, 55, suffered a heart attack in his home outside Fisher Branch, Man.; however, his family and friends were unable to connect to 911 due to the outage. He died later that night. Two months later, on May 16, Telus filed a three-page final report following an investigation on the outage. Moroz stated during question period on Tuesday that he sold his shares in Telus on May 8, but added that the information was already public knowledge. 'On April 8, CTV published their story. This is important, because the outage and Telus' responsibility was public information,' he said. 'The next day, my office wrote a letter to Telus expressing outrage over the situation at the way it was handled and urging them to work with the CRTC, which regulates them, and all other levels of government, to provide the answers and assurance that this would not happen again.' The minister explained he sold his shares in Telus as he wanted to go 'above and beyond the recommendations,' adding that he lost money on the transaction. 'The accusations are baseless,' Moroz said during question period. 'I acted based on publicly available information and media reporting. If the opposition had done their research properly, they also would've made this determination.' During Tuesday's question period, Opposition Leader Obby Khan said there seems to be a 'direct conflict of interest and violation,' adding that Moroz was privy to insider information regarding a 'damaging' Telus report. 'The questions Manitobans have is something looks fishy here, something looks wrong,' Khan said. 'We ask questions, Manitobans deserve answers.'
Globe and Mail
5 days ago
- Business
- Globe and Mail
Collin Kettell buying at Palisades Goldcorp (PALI)
, CEO, acquired 129,500 Common Shares on a direct ownership basis at prices ranging from $0.860 to $0.950 between May 20th, 2025 and May 21st, 2025. This represents a $116,750 investment into the company's shares and an account share holdings change of 0.8%. Let the insiders guide you to opportunity at
